Cite
HARVARD Citation
Maggio, A. et al. (2020). Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial. Lancet. 7 (6), pp. e469-e478. [Online].